Paper26414764
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
De Rosa V and 17 others. Nat Immunol, 2015. Cited by 349 papers, by iCite.
Cite this record
ConductScience Library. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Papers, record 26414764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26414764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Forkhead Transcription Factors | Major topic |
| Glycolysis | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Adult | |
| Alternative Splicing | |
| Autoimmunity | |
| Biomarkers, Tumor | |
| CD4-Positive T-Lymphocytes | |
| Case-Control Studies | |
| DNA-Binding Proteins | |
| Exons | |
| Fatty Acids | |
| Female | |
| Gene Knockdown Techniques | |
| Genetic Variation | |
| Humans | |
| In Vitro Techniques | |
| Male | |
| Metabolome | |
| Middle Aged | |
| Multiple Sclerosis, Relapsing-Remitting | |
| Oxidation-Reduction | |
| Phosphopyruvate Hydratase | |
| RNA, Messenger | |
| Receptors, Antigen, T-Cell | |
| Signal Transduction | |
| Tumor Suppressor Proteins | |
| Young Adult |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 310496 | European Research Council | International | PubMed | PubMed | |
| R21 AI109677 | NIAID NIH HHS | United States | R21AI109677 | PubMed and NIH | NIH RePORTER |
| AI109677 | NIAID NIH HHS | United States | R21AI109677 | PubMed and NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04121065 | Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS) | Background | ClinicalTrials.gov | |
| NCT05245344 | Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study | Background | ClinicalTrials.gov |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16211090 | The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. | J Clin Invest | 2005 | https://conductscience.org/library/papers/16211090 | PubMed |
| 2 | 18368049 | TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. | Nature | 2008 | https://conductscience.org/library/papers/18368049 | PubMed |
| 3 | 25437876 | Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. | J Clin Invest | 2015 | https://conductscience.org/library/papers/25437876 | PubMed |
| 4 | 19801514 | Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. | J Immunol | 2009 | https://conductscience.org/library/papers/19801514 | PubMed |
| 5 | 14597769 | Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. | J Clin Invest | 2003 | https://conductscience.org/library/papers/14597769 | PubMed |
| 6 | 14676299 | Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. | J Exp Med | 2003 | https://conductscience.org/library/papers/14676299 | PubMed |
| 7 | 23801992 | Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function. | Front Immunol | 2013 | https://conductscience.org/library/papers/23801992 | PubMed |
| 8 | 17273171 | Regulatory T cell development in the absence of functional Foxp3. | Nat Immunol | 2007 | https://conductscience.org/library/papers/17273171 | PubMed |
| 9 | 20660617 | TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. | J Exp Med | 2010 | https://conductscience.org/library/papers/20660617 | PubMed |
| 10 | 17616978 | RETRACTED: DNA damage, homology-directed repair, and DNA methylation. | PLoS Genet | 2007 | https://conductscience.org/library/papers/17616978 | PubMed |
| 11 | 18509048 | T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18509048 | PubMed |
| 12 | 18354202 | Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. | J Immunol | 2008 | https://conductscience.org/library/papers/18354202 | PubMed |
| 13 | 24981853 | T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization In Vivo. | Immunity | 2014 | https://conductscience.org/library/papers/24981853 | PubMed |
| 14 | 21488890 | T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. | Immunol Rev | 2011 | https://conductscience.org/library/papers/21488890 | PubMed |
| 15 | 19754613 | Definition, epidemiology and classification of diabetes in children and adolescents. | Pediatr Diabetes | 2009 | https://conductscience.org/library/papers/19754613 | PubMed |
| 16 | 25999944 | Early-onset autoimmune disease as a manifestation of primary immunodeficiency. | Front Immunol | 2015 | https://conductscience.org/library/papers/25999944 | PubMed |
| 17 | 15753318 | De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15753318 | PubMed |
| 18 | 17220874 | Foxp3-dependent programme of regulatory T-cell differentiation. | Nature | 2007 | https://conductscience.org/library/papers/17220874 | PubMed |
| 19 | 15642786 | Identification of alpha-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex. | J Endocrinol | 2005 | https://conductscience.org/library/papers/15642786 | PubMed |
| 20 | 20732639 | Interleukin-2 receptor signaling: at the interface between tolerance and immunity. | Immunity | 2010 | https://conductscience.org/library/papers/20732639 | PubMed |
Cited by259
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 349 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650822 | Enolase-1 and Inflammation. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650822 | PubMed |
| 42635391 | The Glucose Transporter GLUT3 Controls Regulatory T Cell Function. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42635391 | PubMed |
| 42634811 | Lipid Metabolism in Regulatory T Cells in Health and Disease. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42634811 | PubMed |
| 42634089 | Metabolic switch: lymphocytes and the onset of T-cell-mediated autoimmunity. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42634089 | PubMed |
| 42488849 | Modulation of TH17 cell activity by REV-ERB agonists: path toward novel treatments for canine meningoencephalitis of unknown origin. | npj Vet Sci | 2026 | https://conductscience.org/library/papers/42488849 | PubMed |
| 42479459 | SREBP1c modulates Treg immunobiology through a phospholipid-dependent adenosine pathway. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42479459 | PubMed |
| 42450051 | FOXP3 Mutations and Instability as Determinants of Regulatory T-Cell Plasticity in Endocrine Autoimmunity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450051 | PubMed |
| 42365184 | SLC7A11 deficiency exacerbates systemic lupus erythematosus by inducing instability and ferroptosis in regulatory T cells. | Commun Biol | 2026 | https://conductscience.org/library/papers/42365184 | PubMed |
| 42270426 | ATP Inside and Out: Understanding Atherosclerosis Through Energy Metabolism and Purinergic Signaling. | J Atheroscler Thromb | 2026 | https://conductscience.org/library/papers/42270426 | PubMed |
| 42213824 | SRSF3 determines Treg cell fate in antitumor immunity and autoimmunity. | Sci Adv | 2026 | https://conductscience.org/library/papers/42213824 | PubMed |
| 41974917 | MAIT cell plasticity generates CD4+ MAIT cells that promote HCC progression via metabolic crosstalk with tumor cells. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/41974917 | PubMed |
| 41789099 | Leishmania mediated regulation of host metabolism: impact on host immunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/41789099 | PubMed |
| 41746743 | CD38 expression by neonatal human naive CD4+ T cells shapes their distinct metabolic and tolerogenic properties. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41746743 | PubMed |
| 41677725 | Beyond Conventional Transcriptional Regulation Function: FOXP3 as an Integrative Hub for Chromatin Interactions and Protein Complexes in Immune Regulation. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41677725 | PubMed |
| 41659857 | New insights into the tumor immune microenvironment and immunotherapy of thyroid cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/41659857 | PubMed |
| 41582215 | Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41582215 | PubMed |
| 41557725 | Targeting immunometabolism in cancer through pharmacological and lifestyle interventions. | PLoS Biol | 2026 | https://conductscience.org/library/papers/41557725 | PubMed |
| 41469379 | mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41469379 | PubMed |
| 41459507 | Metabolic regulation of regulatory T cells: mechanisms, heterogeneity, and implications in disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459507 | PubMed |
| 41406407 | Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2026 | https://conductscience.org/library/papers/41406407 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26414764
GET https://conductscience.org/api/papers/v1/26414764/references?page=2